Overview

A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks

Status:
Terminated

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

Summary

The main purpose of this research study is to try to improve the results of the standard treatment for heart attacks. Normally, heart attack patients get a fast dose and a slow dose of eptifibatide in the emergency room, shortly after arriving. This drug is usually given through a vein in the arm. However, eptifibatide can also be injected directly into the heart's blood supply just before angioplasty, a common procedure to unblock a blood vessel in the heart. This new way of giving the drug is being studying.

Phase:

Phase 2

Details

Lead Sponsor:

Brigham and Women's Hospital

Collaborator:

Schering-Plough

Treatments:

Eptifibatide